Language
- English
- 中文
- Deutsch

Patient-centered, physician-partner, employee-based

Company News

Product News

Media

Home page

FCVB Obtains Thailand Certification, Empowered by Multiple International Accreditations, Unlocking New Territories in Overseas Markets!

Release time: Mar 31,2026

Another major breakthrough has been achieved for the domestically developed Foldable Capsular Vitreous Body (FCVB)! On March 20, FCVB was successfully granted Thailand Medical Device Registration Certification, officially approving its access to the Thai market. This marks a crucial step in the layout of this internationally pioneering ophthalmic innovative product in the Southeast Asian market, and further demonstrates the innovation strength and international competitiveness of China’s medical devices.

Core Breakthrough: FCVB Secures Thailand Certification, Expanding Footprint in Southeast Asian Market

As an internationally pioneering innovative technology for eye salvage, FCVB is independently developed by Vesber Biotechnology Co., Ltd., representing a high-end ophthalmic implant device entirely researched and manufactured in China. Its core advantage lies in its ability to accurately simulate the structure and function of the human vitreous body, breaking foreign technological monopolies. The National Medical Products Administration of China has recognized FCVB as a typical example of China’s medical device industry transforming from "Made in China" to "Created in China".

Designed to mimic the morphology of the human vitreous cavity, FCVB can be permanently implanted in the eye, effectively solving clinical dilemmas of traditional vitreous substitutes, such as inability to remain in the eye long-term and the need for repeated surgeries. It helps patients with severe ocular trauma and silicone oil-dependent eyes preserve their eyeballs, avoiding enucleation and ocular prosthesis implantation, thus greatly reducing the physical, psychological and financial burdens on patients.

Since its approval for the domestic market in 2017, FCVB has been clinically applied in more than 300 hospitals across 11 countries worldwide, serving over 6,000 patients, and its clinical value has been widely recognized by ophthalmologists both at home and abroad. The entry into the Thai market will provide a novel treatment option for local patients suffering from severe ocular trauma, retinal detachment and other ophthalmic diseases, helping to elevate the level of ophthalmic medical care in Thailand. Meanwhile, it lays a solid foundation for FCVB to further explore markets in Southeast Asia and globally, enabling domestic advanced ophthalmic innovative technologies to benefit more international patients.

Global Recognition: Backed by Multiple Certifications, Demonstrating the Strength of Domestic Medical Devices

The acquisition of Thailand Medical Device Registration Certification is not FCVB’s first international recognition. To date, FCVB has established a comprehensive international accreditation system. It has successively obtained ISO 13485 Quality Management System Certification, MDSAP (Medical Device Single Audit Program) Certification, as well as market access qualifications in numerous countries and regions including Canada, Saudi Arabia, Singapore and Australia (TGA Registration). It has also secured approval in Hong Kong, China and multiple international patents, fully proving that its product quality, safety and efficacy have reached international advanced standards.

Back to list

Related Information

FCVB Obtains Thailand Certification, Empowered by Multiple International Accreditations, Unlocking New Territories in Overseas Markets!

View Details

3D Reconstruction of FCB Successfully Published in Clinical Ophthalmology

This research not only shortens the learning curve and lowers the technical threshold of FCB surgery, but also lays a solid foundation for its standardized promotion in primary hospitals and among special populations (such as children, pregnant women, and highly myopic patients), truly realizing a minimally invasive, precise and reproducible clinical pathway.

03/31

FCVB Secures Singapore Medical Device Registration, Reinforcing Chinese Ophthalmic Innovation Leadership

03/02

Analysis of the Efficacy of Foldable Capsular Buckle (FCB) Scleral Buckling in Treating Rhegmatogenous Retinal Detachment: Chinese Instruction Course (IC) Successfully Held at the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO 2026)

The APAO 2026 congress served as an academic feast and international exchange platform for the ophthalmology community. As a globally innovative technology, the Foldable Capsular Buckle (FCB) sparked considerable discussion at APAO 2026, fully reflecting the technology's visibility and research depth

02/10

First in Qinghai! Xining Aier Eye Hospital Successfully Implements New Minimally Invasive Technology for Rapid Retinal Detachment Treatment

On the day of the surgery, Professor Hou Lei and Professor Chen Zhongping worked closely together, leveraging their exceptional medical skills and seamless collaboration to successfully complete Qinghai Province's first FCB procedure.

02/05

Ophthalmology Department of Dunhua Traditional Chinese Medicine Hospital Takes the Lead in Performing Highly Difficult Foldable Capsular Vitreous Body (FCVB) Implantation

01/13

R&D Center

Media

Cases

Search for product information you are interested in

all

all
product management
News

+8618960050093

Building11,No.6,Nanjiang 2nd Road, Zhujiang Street, Nansha District,Guangzhou

www.vesber.cn

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

License